|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
2
GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy
3
Factors Contributing to the Growth of Radiopharmaceuticals: Q&A with Andrea Zobel and Marco Hogenboom
4
FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection
5